Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0773-2016

Drug recall · March 23, 2016

NABUMETONE Tablets USP recall

Why: Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL

Lots / codes

Lot #: 05N533, Exp 11/16

Quantity
576 bottles
Company
Teva Pharmaceuticals USA, North Wales, PA
Distribution
Nationwide and Puerto Rico.
Initiated
November 19, 2015 · Voluntary: Firm initiated
Classified
March 11, 2016
Reported
March 23, 2016
Ended
November 15, 2016
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Nabumetone

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.